Syros Pharmaceuticals Inc (OQ:SYRS)

Business Focus: Biopharmaceuticals

Competitors with Recent Insider Filings
Biogen (OQ:BIIB)
Allakos (OQ:ALLK)
BioMarin Pharmaceutical (OQ:BMRN)
Latest 10 SEC filings (by transaction date) for SYRS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET September 14th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Aug 19/19 Aug 16/19 Young Richard A Direct Ownership Common Stock S - Open market or private sale -22,700 $10.00
Aug 19/19 Aug 15/19 Young Richard A Direct Ownership Common Stock S - Open market or private sale -2,300 $10.00
Jul 17/19 Jul 17/19 ARCH Venture Fund VII, L.P. Direct Ownership Common Stock S - Open market or private sale -34,521 $7.70
Jul 17/19 Jul 16/19 ARCH Venture Fund VII, L.P. Direct Ownership Common Stock S - Open market or private sale -25,779 $7.81
Jul 17/19 Jul 15/19 ARCH Venture Fund VII, L.P. Direct Ownership Common Stock S - Open market or private sale -2,700 $8.27
Jun 12/19 Jun 11/19 Young Richard A Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 11,000  
Jun 12/19 Jun 11/19 Wirth Peter Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 11,000  
Jun 12/19 Jun 11/19 Shaw Alice Tsang Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 22,000  
Jun 12/19 Jun 11/19 Sharp Philip A Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 11,000  
Jun 12/19 Jun 11/19 Sato Vicki L Direct Ownership Common Stock (right to buy) A - Grant, award or other under Rule 16b-3(d) 11,000  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for SYRS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET September 14th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Aug 19/19 Aug 16/19 Young Richard A Direct Ownership Common Stock S - Open market or private sale -22,700 $10.00
Aug 19/19 Aug 15/19 Young Richard A Direct Ownership Common Stock S - Open market or private sale -2,300 $10.00
Jul 17/19 Jul 17/19 ARCH Venture Fund VII, L.P. Direct Ownership Common Stock S - Open market or private sale -34,521 $7.70
Jul 17/19 Jul 16/19 ARCH Venture Fund VII, L.P. Direct Ownership Common Stock S - Open market or private sale -25,779 $7.81
Jul 17/19 Jul 15/19 ARCH Venture Fund VII, L.P. Direct Ownership Common Stock S - Open market or private sale -2,700 $8.27
Jun 12/19 Jun 11/19 Young Richard A Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 11,000  
Jun 12/19 Jun 11/19 Wirth Peter Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 11,000  
Jun 12/19 Jun 11/19 Shaw Alice Tsang Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 22,000  
Jun 12/19 Jun 11/19 Sharp Philip A Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 11,000  
Jun 12/19 Jun 11/19 Sato Vicki L Direct Ownership Common Stock (right to buy) A - Grant, award or other under Rule 16b-3(d) 11,000  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $SYRS

StockTwits